BW
WHWK

Bison Wealth’s Whitehawk Therapeutics WHWK Stock Holding History

Bison Wealth’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-848
Closed -$16K – 500
2021
Q1 		$16K Sell
848
-319
-27% -$7.34K 0.01% 383
2020
Q4 		$17K Hold
1,167
– – 0.01% 336
2020
Q3 		$26K Buy
1,167
+67
+6% +$1.41K 0.02% 277
2020
Q2 		$21K Buy
+1,100
New +$14.4K 0.01% 285

Other funds holding WHWK

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Bison Wealth's WHWK Position: Q2 2021 in Review

Bison Wealth sold out of Whitehawk Therapeutics (WHWK) in Q2 2021, closing a stake of 848 shares — an estimated $16K sold.

Bison Wealth first reported a position in WHWK in Q2 2020 and held it in 4 quarters. The position peaked at $26K in Q3 2020. 42 funds tracked by Wall St. Rank hold WHWK as of Q2 2021.

  • Bison Wealth reported no remaining Whitehawk Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bison Wealth sold 848 Whitehawk Therapeutics shares in Q2 2021, an estimated $16K.
  • Bison Wealth first reported a position in Whitehawk Therapeutics in Q2 2020 and held it in 4 quarters.
  • Bison Wealth's Whitehawk Therapeutics position peaked at $26K in Q3 2020.
  • 42 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2021.

Based on Bison Wealth's 13F filing for Q2 2021, filed 2 Aug 2021.